IN2014MN01381A - - Google Patents

Info

Publication number
IN2014MN01381A
IN2014MN01381A IN1381MUN2014A IN2014MN01381A IN 2014MN01381 A IN2014MN01381 A IN 2014MN01381A IN 1381MUN2014 A IN1381MUN2014 A IN 1381MUN2014A IN 2014MN01381 A IN2014MN01381 A IN 2014MN01381A
Authority
IN
India
Prior art keywords
formulations
novel method
dry
biomolecules
reconstitution
Prior art date
Application number
Inventor
Jan Vos
Andrew John Macleod
Original Assignee
Xstalbio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xstalbio Ltd filed Critical Xstalbio Ltd
Publication of IN2014MN01381A publication Critical patent/IN2014MN01381A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Degasification And Air Bubble Elimination (AREA)
  • Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)

Abstract

The present invention relates to the provision of a novel method for the reconstitution of dry formulations comprising biomolecules and in particular to dry protein formulations and to pharmaceutical or veterinary products suitable for parenteral administration containing reconstituted formulations prepared according to the novel method of the invention.
IN1381MUN2014 2011-12-23 2012-12-24 IN2014MN01381A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1122430.0A GB201122430D0 (en) 2011-12-23 2011-12-23 Reconstitution method for high concentration dry protein formulation
PCT/GB2012/053266 WO2013093525A1 (en) 2011-12-23 2012-12-24 Reconstitution method for high concentration dry protein formulations

Publications (1)

Publication Number Publication Date
IN2014MN01381A true IN2014MN01381A (en) 2015-04-17

Family

ID=45695059

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1381MUN2014 IN2014MN01381A (en) 2011-12-23 2012-12-24

Country Status (8)

Country Link
US (1) US20140308293A1 (en)
EP (1) EP2793852A1 (en)
JP (1) JP2015511129A (en)
BR (1) BR112014015605A2 (en)
CA (1) CA2859287A1 (en)
GB (1) GB201122430D0 (en)
IN (1) IN2014MN01381A (en)
WO (1) WO2013093525A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201313368D0 (en) 2013-07-26 2013-09-11 Xstalbio Ltd Novel Reconstitution devices
US20170274012A1 (en) * 2014-09-03 2017-09-28 Entegrion, Inc. Acceleration of Reconstitution of Plasma Powder by Mixing with Small Beads
US10143625B2 (en) 2015-03-17 2018-12-04 Recon Therapeutics, Inc. Pharmaceutical reconstitution
CN110198952B9 (en) 2016-08-17 2024-05-28 勃林格殷格翰国际公司 Method for preparing highly concentrated liquid formulations containing biomolecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178884A (en) * 1988-05-18 1993-01-12 Cryopharm Corporation Lyophilized and reconstituted red blood cell compositions
DE4416166C2 (en) * 1994-05-06 1997-11-20 Immuno Ag Stable preparation for the treatment of blood clotting disorders
DE10211227A1 (en) * 2002-03-13 2003-10-02 Aventis Behring Gmbh Process for the reconstitution of lyophilized proteins
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
EP1958618A1 (en) * 2007-02-15 2008-08-20 Octapharma AG Method for freeze-drying with optimum reconstitution of biopolymers
US20120121580A1 (en) 2009-07-28 2012-05-17 Merck Sharp & Dohme Corp. Methods for producing high concentration lyophilized pharmaceutical formulations

Also Published As

Publication number Publication date
CA2859287A1 (en) 2013-06-27
JP2015511129A (en) 2015-04-16
WO2013093525A1 (en) 2013-06-27
BR112014015605A2 (en) 2017-07-04
GB201122430D0 (en) 2012-02-08
EP2793852A1 (en) 2014-10-29
US20140308293A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
IL238301A0 (en) Drug delivery conjugates containing unnatural amino acids and methods for using
IL254879B (en) Non-natural amino acid linked dolastatin derivatives and pharmaceutical compositions containing them
AR093377A1 (en) ANTI-NOTCH ANTIBODIES AND ANTIBODY-FARMACO CONJUGATES
IL222120A (en) (indol-1-yl)-carbonylalkyl derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating cancer
PL3222952T3 (en) Method and system for freeze-drying injectable compositions, in particular pharmaceutical compositions
WO2012135805A3 (en) Delivery and formulation of engineered nucleic acids
FR2986002B1 (en) NOVEL INDOLIZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL230874A (en) Bicyclic dihydroquinolin-2-one derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments
IL223795A (en) Tetrahydro-pyrido-pyrimidine derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments
MX2015000337A (en) Etanercept formulations exhibiting marked reduction in sub-visible particles.
IL240496B (en) Pyridine derivatives, process for their preparation, pharmaceutical compositions comprising same and their ust in therapy
NZ708016A (en) Lyophilized preparations of melphalan flufenamide
PL2760878T3 (en) Ester-1,3,5 (10), 16-tetraene-3-carboxamide derivatives, their preparation, pharmaceutical preparations containing them and their use in the production of drugs
IL226205B (en) Fusion proteins, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for cancer therapy
LT2717914T (en) SLOW-RELEASE COMPOSITIONS FOR ADMINISTRATION OF PROTEINS IN THE EYE AND METHODS OF THEIR PREPARATION
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
IL231050A0 (en) Substituted 4,5,6,7-terahydro1h-pyrazolo[4,3-c]pyridines,their use as medicament,and pharmaceutical preparations comprising them
MX2013013649A (en) Quinone compounds for treating ape1 mediated diseases.
PL2911524T3 (en) Method for producing protein compositions of low solubility, compositions produced, and use thereof in bread-making products
IN2014MN01381A (en)
ZA201209674B (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
MX355719B (en) Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum.
FR2994634B1 (en) FRESH SPIRULINA FOOD COMPOSITION AND PROCESS FOR PREPARING THE SAME
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
ZA201409481B (en) Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same